From Infection to Death: An Overview of the Pathogenesis of Visceral Leishmaniasis
Pathogens · 24.07.2023 · 12 (7) · 969
DOI: 10.3390/pathogens12070969 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pathogens, online erschienen am 24.07.2023. Verfasst von Carlos H N Costa und 3 weiteren Autor:innen. Beteiligte Einrichtung: Centro de Investigações em Agravos Tropicais Emergentes e Negligenciados, Instituto de Doenças Tropicais Natan Portella, Universidade Federal do Piau…. Die Arbeit wurde bisher 106-mal zitiert (Crossref) und nennt 208 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico - CNPq, Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) fellowship.
Abstract (Originalsprache)
Kala-azar, also known as visceral leishmaniasis (VL), is a disease caused by Leishmania infantum and L. donovani. Patients experience symptoms such as fever, weight loss, paleness, and enlarged liver and spleen. The disease also affects immunosuppressed individuals and has an overall mortality rate of up to 10%. This overview explores the literature on the pathogenesis of preclinical and clinical stages, including studies in vitro and in animal models, as well as complications and death. Asymptomatic infection can result in long-lasting immunity. VL develops in a minority of infected individuals when parasites overcome host defenses and multiply in tissues such as the spleen, liver, and bone marrow. Hepatosplenomegaly occurs due to hyperplasia, resulting from parasite proliferation. A systemic inflammation mediated by cytokines develops, triggering acute phase reactants from the liver. These cytokines can reach the brain, causing fever, cachexia and vomiting. Similar to sepsis, disseminated intravascular coagulation (DIC) occurs due to tissue factor overexpression. Anemia, hypergammaglobulinemia, and edema result from the acute phase response. A regulatory response and lymphocyte depletion increase the risk of bacterial superinfections, which, combined with DIC, are thought to cause death. Our understanding of VL’s pathogenesis is limited, and further research is needed to elucidate the preclinical events and clinical manifestations in humans.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Centro de Investigações em Agravos Tropicais Emergentes e Negligenciados, Instituto de Doenças Tropicais Natan Portella, Universidade Federal do Piauí, Rua Artur de Vasconcelos 151-Sul, Teresina 64002-510, PI, Brazil.
- Department of Microbiology/Immunology, Center for Cancer Cell Biology, Immunology & Infection, Chicago Medical School, Rosalind Franklin University, North Chicago, IL 60064, USA.
- Departament of Physiotherapy, Centro Universitário Uninovafapi, Rua Vitorino Orthiges Fernandes, 6123-Uruguai, Teresina 64073-505, PI, Brazil.
ORCID-Profile: Carlos H N Costa
Förderung
- Conselho Nacional de Desenvolvimento Científico e Tecnológico - CNPq
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) fellowship
Zitieren
APA
Costa, C. H. N., Chang, K. P., Costa, D. L., & Cunha, F. V. M. (2023). From Infection to Death: An Overview of the Pathogenesis of Visceral Leishmaniasis. Pathogens, 12(7), 969. https://doi.org/10.3390/pathogens12070969
Vancouver
Costa CHN, Chang KP, Costa DL, Cunha FVM. From Infection to Death: An Overview of the Pathogenesis of Visceral Leishmaniasis. Pathogens. 2023;12(7):969. doi:10.3390/pathogens12070969
BibTeX
@article{Costa2023,
author = {Costa, Carlos H N and Chang, Kwang-Poo and Costa, Dorcas L and Cunha, Francisco Valmor M},
title = {From Infection to Death: An Overview of the Pathogenesis of Visceral Leishmaniasis},
journal = {Pathogens},
year = {2023},
volume = {12},
number = {7},
pages = {969},
doi = {10.3390/pathogens12070969}
}
EUVIMED